Suppr超能文献

慢性吸食大麻花、吸食大麻浓缩物和不使用者的认知测试表现。

Cognitive test performance in chronic cannabis flower users, concentrate users, and non-users.

机构信息

Department of Psychology, Washington State University, PO Box 644820, Pullman, WA, 99164-4820, USA.

出版信息

Sci Rep. 2023 May 18;13(1):8068. doi: 10.1038/s41598-023-35217-1.

Abstract

Extremely high-potency cannabis concentrates are becoming increasingly available and popular among consumers. While prior research indicates these products are perceived to have greater detrimental effects relative to cannabis flower, few studies have examined their relative objective effects, and no existing studies have compared the cognitive test performance of sober flower users, concentrate users, and non-users. A total of 198 healthy adults (98 non-users, 46 exclusive flower users, and 54 concentrate users) were administered a battery of tests of memory, psychomotor speed, attention, and executive functioning under sober laboratory-controlled conditions. Significant group differences were detected on tests of verbal free recall and episodic prospective memory, with both the flower users and concentrate users demonstrating significantly worse performance than non-users. Concentrate (but not flower) users performed worse than non-users on a measure of source memory, but contrary to our hypothesis, there were no significant differences between flower and concentrate users on any of the cognitive tests. Results indicate that, under sober conditions, individuals who regularly use concentrates are no more cognitively impacted than those who exclusively use flower. These null findings may reflect the tendency for concentrate users to self-titrate and use significantly lower quantities of concentrates than flower.

摘要

高浓度大麻浓缩物在消费者中越来越受欢迎。尽管先前的研究表明,与大麻花相比,这些产品被认为具有更大的有害影响,但很少有研究检查它们的相对客观影响,也没有现有的研究比较清醒的花使用者、浓缩物使用者和非使用者的认知测试表现。共有 198 名健康成年人(98 名非使用者、46 名纯花使用者和 54 名浓缩物使用者)在清醒的实验室控制条件下接受了一系列记忆、心理运动速度、注意力和执行功能测试。在言语自由回忆和情节前瞻性记忆测试中,发现了显著的组间差异,花使用者和浓缩物使用者的表现明显逊于非使用者。浓缩物(而非花)使用者在源记忆测试中的表现逊于非使用者,但与我们的假设相反,在任何认知测试中,花使用者和浓缩物使用者之间均无显著差异。结果表明,在清醒状态下,经常使用浓缩物的个体在认知上受到的影响并不比仅使用花的个体大。这些无效的发现可能反映了浓缩物使用者自我调整并使用明显低于花的浓缩物的倾向。

相似文献

1
Cognitive test performance in chronic cannabis flower users, concentrate users, and non-users.
Sci Rep. 2023 May 18;13(1):8068. doi: 10.1038/s41598-023-35217-1.
2
Association of Naturalistic Administration of Cannabis Flower and Concentrates With Intoxication and Impairment.
JAMA Psychiatry. 2020 Aug 1;77(8):787-796. doi: 10.1001/jamapsychiatry.2020.0927.
4
Cannabis Involvement and Demand in Frequent Concentrate Users Versus Predominantly Flower Users.
J Stud Alcohol Drugs. 2023 Mar;84(2):214-221. doi: 10.15288/jsad.22-00066. Epub 2022 Oct 14.
5
Made from concentrate? A national web survey assessing dab use in the United States.
Drug Alcohol Depend. 2018 Sep 1;190:133-142. doi: 10.1016/j.drugalcdep.2018.05.022. Epub 2018 Jun 26.
6
A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment.
Psychopharmacology (Berl). 2022 Feb;239(2):385-397. doi: 10.1007/s00213-021-06007-2. Epub 2021 Oct 27.
7
Exploring survey methods for measuring consumption quantities of cannabis flower and concentrate products.
Am J Drug Alcohol Abuse. 2023 Nov 2;49(6):733-745. doi: 10.1080/00952990.2023.2246635. Epub 2023 Dec 11.
8
Associations between self-reported cannabis use frequency, potency, and cannabis/health metrics.
Int J Drug Policy. 2021 Nov;97:103278. doi: 10.1016/j.drugpo.2021.103278. Epub 2021 May 30.
9
Use of highly-potent cannabis concentrate products: More common in U.S. states with recreational or medical cannabis laws.
Drug Alcohol Depend. 2021 Dec 1;229(Pt B):109159. doi: 10.1016/j.drugalcdep.2021.109159. Epub 2021 Oct 29.
10
Female Sex as a Protective Factor in the Effects of Chronic Cannabis Use on Verbal Learning and Memory.
J Int Neuropsychol Soc. 2021 Jul;27(6):581-591. doi: 10.1017/S1355617721000217.

本文引用的文献

1
Adult use of highly-potent Δ9-THC cannabis concentrate products by U.S. state cannabis legalization status, 2021.
Addict Behav. 2023 May;140:107617. doi: 10.1016/j.addbeh.2023.107617. Epub 2023 Jan 10.
2
Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios.
Neuropsychopharmacology. 2023 May;48(6):869-876. doi: 10.1038/s41386-022-01478-z. Epub 2022 Nov 16.
5
Associations between self-reported cannabis use frequency, potency, and cannabis/health metrics.
Int J Drug Policy. 2021 Nov;97:103278. doi: 10.1016/j.drugpo.2021.103278. Epub 2021 May 30.
6
Effects of High-Potency Cannabis on Psychomotor Performance in Frequent Cannabis Users.
Cannabis Cannabinoid Res. 2022 Feb;7(1):107-115. doi: 10.1089/can.2020.0048. Epub 2020 Sep 10.
7
Advancing the science on cannabis concentrates and behavioural health.
Drug Alcohol Rev. 2021 Sep;40(6):900-913. doi: 10.1111/dar.13281. Epub 2021 Mar 30.
8
Current U.S. State Cannabis Sales Limits Allow Large Doses for Use or Diversion.
Am J Prev Med. 2021 May;60(5):701-705. doi: 10.1016/j.amepre.2020.11.005. Epub 2021 Feb 12.
9
A within-person comparison of the subjective effects of higher vs. lower-potency cannabis.
Drug Alcohol Depend. 2020 Nov 1;216:108225. doi: 10.1016/j.drugalcdep.2020.108225. Epub 2020 Aug 19.
10
Association of Naturalistic Administration of Cannabis Flower and Concentrates With Intoxication and Impairment.
JAMA Psychiatry. 2020 Aug 1;77(8):787-796. doi: 10.1001/jamapsychiatry.2020.0927.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验